by John A. Jenkins | Jan 31, 2024 | FDA, FOIA, SEC, Short-Selling, Stock Market
FOIAengine: Short Seller Fahmi Quadir Goes for Another Kill To keep a nickname like “the Assassin,” the killer better not miss. By the time short seller Fahmi Quadir was scheduled to take the stage on January 30 at a big investment conference in Miami Beach, she had...
by Randy E. Miller | Dec 13, 2023 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Short-Selling, Stock Market
FOIAengine Reveals FOIA Requests About Establishment Labs Food and Drug Administration FOIA records released this month reveal that breast implant manufacturer Establishment Labs (NASDAQ: ESTA), previously targeted by well-known activist short-seller Hindenburg...
by John A. Jenkins | Dec 6, 2023 | FOIA, SEC, Short-Selling, Stock Market
Another Short Seller Hits FOIAengine’s Radar It gets our attention when a short seller hits FOIAengine’s radar for the first time. This week, we’re talking about Nathan Koppikar – Nate, for short – and his impactful short-seller fund, Orso Partners. Orso means “bear”...
by John A. Jenkins | Oct 5, 2023 | Banking, FOIA, SEC, Short-Selling, Stock Market
FOIAengine: LA’s Steven Sugarman Goes After Carson Block and Muddy Waters Jason Galanis is Inmate 80739-198, currently locked up in a federal prison in Montgomery, Alabama. Galanis is a member of a notorious crime family, a recidivist white-collar criminal doing...
by John A. Jenkins | Sep 27, 2023 | Banking, Cryptocurrency, FOIA, SEC, Stock Market
FOIAengine: As Trial Looms, a Private Investigator Pursues the SEC It’s been a tough couple of months for Sam Bankman-Fried. He’s stewing in jail, facing 155 years in prison, while lawyers, accountants, and other experts rack up $700 million in fees from the crypto...
by Randy E. Miller | Sep 20, 2023 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Short-Selling, Stock Market
FOIAengine Identifies 57 New FOIA Requests to FDA Hedge funds and other financial institutions made 57 Freedom of Information Act (FOIA) requests last month to the Food and Drug Administration (FDA) seeking information about adverse drug events and...
